Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-10 | Thomas D. Kiley, Esq., has served as a director of the Company since September 1992. Mr. Kiley is also a director of Transcept Pharmaceuticals, Inc. and certain privately held biotechnology and other companies. He has been self-employed since 1988 as an attorney, consultant and investor. From 1980 to 1988, he was an officer of Genentech, Inc., a biotechnology company, serving variously as Vice President and General Counsel, Vice President for Legal Affairs and Vice President for Corporate Development. From 1969 to 1980, he was with the Los Angeles law firm of Lyon & Lyon and was a partner at the firm from 1975 to 1980. Mr. Kiley holds a B.S. in Chemical Engineering from Pennsylvania State University and a J.D. from George Washington University. |
| 2010-03-29 | Thomas D. Kiley, Esq., has served as a director of the Company since September 1992. ... The Audit Committee, which is comprised of Ms. Eastham and Messrs. Fritzky and Kiley, ... The following table provides compensation information for the year ended December 31, 2009 for each non-employee member of the Board. ... Kiley, Thomas $ 29,750 (3) $ 167,075 $ 57,961 $— $— $— $ 254,786 |
| 2011-03-28 | Thomas D. Kiley, Esq., has served as a director of the Company since September 1992. The Audit Committee, which is comprised of Ms. Eastham and Messrs. Fritzky and Kiley. The following table provides compensation information for the year ended December 31, 2010 for each non-employee member of the Board. Kiley, Thomas $ 30,500 83,396 46,704 160,600 |
| 2012-04-03 | Thomas D. Kiley, Esq., served as a director of the Company since September 1992... The Audit Committee, which is comprised of Ms. Eastham and Messrs. Fritzky and Kiley... Director Compensation Table shows total compensation of $146,384. |
Data sourced from SEC filings. Last updated: 2026-02-03